US Map / Kansas
State KS

Clinical Trials in Kansas

Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 120 actively recruiting studies with Kansas sites out of 120 registered in total. The busiest research areas in Kansas are Overweight, Obesity, Cystic Fibrosis. Leading sponsors running trials in the state include University of Kansas Medical Center, National Cancer Institute (NCI), SWOG Cancer Research Network. By stage, Kansas trials break down as Phase 1 (17), Phase 2 (34), Phase 3 (36), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
120
Recruiting Now
120
← Back to US Map
Top Conditions in Kansas
Overweight (4)Obesity (4)Cystic Fibrosis (3)Non-alcoholic Fatty Liver Disease (2)Bladder Cancer (2)Breast Carcinoma (2)Breast Ductal Carcinoma In Situ (2)Breast Lobular Carcinoma In Situ (2)Stroke (2)Stage IVB Prostate Cancer AJCC v8 (2)Mitral Regurgitation (2)Osteoarthritis, Knee (2)

Frequently Asked Questions — Clinical Trials in Kansas

How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 120 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 120. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Overweight, Obesity, Cystic Fibrosis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Kansas

NCT05408845 Phase 2
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Ch...
Condition
Metastatic Salivary Gland Carcinoma
Enrollment
146 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT06936566 Phase 2
Recruiting
MAGIC Ruxolitinib for aGVHD
Condition
Acute Graft-versus-host Disease
Enrollment
98 pts
Location
United States
Sponsor
John Levine
View Trial →
NCT06414681 EARLY_Phase 1
Recruiting
Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Hi...
Condition
Myelofibrosis,MF
Enrollment
20 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
NCT04939051 Phase 2
Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus
Condition
Barrett Esophagus
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03802695 Phase 1
Recruiting
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation fo...
Condition
Acute Myeloid Leukemia
Enrollment
300 pts
Location
United States
Sponsor
Orca Biosystems, Inc.
View Trial →
NCT06571669 N/A
Recruiting
BOOM-IBD2 Pivotal Clinical Trial
Condition
Ulcerative Colitis
Enrollment
137 pts
Location
United States
Sponsor
Boomerang Medical
View Trial →
NCT07546929 Phase 2
Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Di...
Condition
Type 2 Diabetes
Enrollment
300 pts
Location
United States
Sponsor
Housey Healthcare ULC
View Trial →
NCT05080673 N/A
Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Condition
Adenocarcinoma of the Colon
Enrollment
9,500 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT04530383 Phase 2
Recruiting
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel ...
Condition
Cystic Fibrosis-related Diabetes
Enrollment
30 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
NCT06233461 Phase 2
Recruiting
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the B...
Condition
Crohn's Disease
Enrollment
268 pts
Location
United States, Australia, Belgium
Sponsor
Takeda
View Trial →
NCT05795465 Phase 2
Recruiting
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Condition
Respiratory Distress Syndrome, Acute
Enrollment
52 pts
Location
United States
Sponsor
GEn1E Lifesciences
View Trial →
NCT06640179 N/A
Recruiting
Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Tr...
Condition
Kidney Transplant
Enrollment
60 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
NCT07437079 Phase 1
Recruiting
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Livin...
Condition
Overweight
Enrollment
96 pts
Location
United States
Sponsor
Novo Nordisk A/S
View Trial →
NCT03808922 Phase 3
Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substu...
Condition
Lower Respiratory Tract Infection
Enrollment
274 pts
Location
United States, Australia, China
Sponsor
Ansun Biopharma, Inc.
View Trial →
NCT06937177 Phase 2
Recruiting
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly...
Condition
Cancer Weight Loss
Enrollment
120 pts
Location
United States, Canada
Sponsor
Endevica Bio
View Trial →
NCT06137339 N/A
Recruiting
AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adult...
Condition
Brain Aging
Enrollment
70 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
NCT06072612 Phase 3
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastat...
Condition
Breast Cancer
Enrollment
404 pts
Location
United States
Sponsor
BriaCell Therapeutics Corporat
View Trial →
NCT06267729 Phase 1, Phase 2
Recruiting
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Condition
Metastatic Prostate Cancer
Enrollment
60 pts
Location
United States, Australia, Spain
Sponsor
AstraZeneca
View Trial →
NCT05986292 Phase 2
Recruiting
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices ...
Condition
Osteoarthritis, Knee
Enrollment
10,000 pts
Location
United States, Puerto Rico
Sponsor
Eli Lilly and Company
View Trial →
NCT02418442 N/A
Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Condition
Rheumatic Joint Disease
Enrollment
20,000 pts
Location
United States, Canada, Israel
Sponsor
Duke University
View Trial →
Page 5 of 5 — 120 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology